A Review on Impurity Profiling, Degradation Studies, and Bioanalytical Methods of Anti-diabetic Drugs
Mahesh M. Deshpande, Madhuri H. Bhalerao & Pooja D. Pabale · Journal of Pharmaceutical Research International · 2022
According to ICH Q3A(R), the impurity in a new drug substance is “any component of a new drug substance that is not the chemical entity defined as a new drug substance”. As Per ICH Q3B(R), the impurity in a new drug product is “any component of the drug product that is not the dr...
Open access
Research Article
10.9734/jpri/2022/v34i34B36156